XpresSpa Group Inc (XSPA)

[~ Blue ~]

300,000 coronavirus tests per week

Two of the largest private labs in the U.S. will collectively be able to process more than 300,000 COVID-19 tests by the end of the week, their CEOs told CNBC.

LabCorp CEO Adam Schechter said the company will soon be able to process more than 100,000 tests weekly.
Quest Diagnostics will soon have the capacity to run around 200,000 tests per week, CEO Steve Rusckowski.

https://www.cnbc.com/2020/03/24/coronavirus-labcorp-quest-diagnostics-are-growing-testing-capacity.html
---------------------------------------------------------------------

XpresSpa Announces Partnership with Relevant Healthcare


GlobeNewswire GlobeNewswire•March 25, 2020
Novel Coronavirus (COVID-19) Testing in U.S. Airports

NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (XSPA) (“XpresSpa” or the “Company”), today announced an update to discussions in converting its spa locations into novel coronavirus (“COVID-19”) testing locations.

XpresSpa will be partnering (the “Partnership”) with Relevant Healthcare Cost Containment®, the registered trade name of Contain Holdings, LLC, an Illinois limited liability company (“Relevant Healthcare”), a Chicago-area healthcare cost containment, payment integrity and transparency company. Relevant Healthcare had previously announced that it is offering testing for COVID-19 (the “COVID-19 testing”) through its contracts with both Laboratory Corporation of America® (“LabCorp”) and Quest Diagnostics™ (“Quest”). Both LabCorp and Quest are the leading laboratory companies in the U.S. and have the current capacity to process tens of thousands of COVID-19 tests per day. All COVID-19 testing will be done by appropriately licensed health professionals in accordance with applicable federal and state laws.

https://finance.yahoo.com/news/xpresspa-announces-partnership-relevant-healthcare-130010579.html

XSPA seeks to support COVID-19 testing in 46 locations across 23 US Airports

XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today announced that it has reached out to multiple government agencies, including the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS), as well as private laboratories across the country.

The Company has engaged in early high-level discussions with regards to turning all of its 46 airport locations, with many, located in point of entry cities, such as New York, Los Angeles, San Francisco, Chicago, Miami, Atlanta, and Washington DC into COVID-19 testing facilities. The Company believes that its spas offer a range of spaces that can be set up to test airport staff, flight crews, and passengers.

The international airports across the United States are on the front lines of defense for combating entry into the US for people with the Cronavirus. Xpresspa, having locations in all of these key ports of entry is uniquely positioned to help in this fight. As a health and wellness company the majority of its employees are state licensed which includes training in disease containment. In addition, XpresSpa employees are already TSA security approved so they can be trained and deployed immediately.

Doug Satzman, XpresSpa, Chief Executive Officer, said, ”We believe we can we help alleviate some of the long waits for travelers entering the US but we can also be available to test TSA employees, pilots, Flight Attendants and other airport personnel who are on the front lines helping to keep our nation safe.”

Doug Satzman, further stated “As the largest operator of health and wellness spas located within these US point of entry airports, we believe our facilities could be of great utility in helping our government test people as quickly as possible. We will work closely with local airport authorities on all plans. While we cannot ensure that an arrangement will ultimately be consummated, we remain optimistic, that we can play a vital role with some of these entities.”


https://secfilings.nasdaq.com/filingFrameset.asp?FilingID=14017377&RcvdDate=3/19/2020&CoName=XPRESSPA%20GROUP%2C%20INC.&FormType=8-K&View=html